IP Library Assignment 048557/0923
Patent Assignment
Reel/Frame 048557/0923

Assignment of Assignor's Interest

Recorded: 2019-03-11 Pages: 10
Assignor
ALLERGAN, INC.
Executed: 2017-05-23
Assignee
SERENITY PHARMACEUTICALS LLC
105 HAWK COURT, MILFORD, PENNSYLVANIA, 18337
Covered Property (1)
Methods and Compositions Comprising Desmopressin in Combination with a Beta-3-Adrenergic Receptor Agonist
Application: 15/811,384 →
Publication: US 2018/0289769
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 11, 2019
From: FEIN, SEYMOUR H.; HERSCHKOWITZ, SAMUEL
To: SERENITY PHARMACEUTICALS LLC
Reel/Frame 048557/0799 →
Assignment of Assignor's Interest Mar 11, 2019
From: SERENITY PHARMACEUTICALS LLC
To: ALLERGAN, INC.
Reel/Frame 048557/0898 →
Change of Name Sep 22, 2022
From: SERENITY PHARMACEUTICALS LLC
To: ACERUS PHARMACEUTICALS USA, LLC
Reel/Frame 061509/0419 →
Security Interest Dec 22, 2022
From: ACERUS PHARMACEUTICALS USA, LLC
To: FIRST GENERATION CAPITAL INC.
Reel/Frame 062185/0506 →
Security Interest Dec 22, 2023
From: ACERUS PHARMACEUTICALS USA, LLC
To: FIRST GENERATION CAPITAL INC.
Reel/Frame 065943/0612 →